Medixa Peptides

Physician-dispensed peptide protocols personalized for each patient.

Sexual Health PT-141 (Bremelanotide)

PT-141 (Bremelanotide)

10 mg vial

Sexual dysfunction, low libido, HSDD

FDA-approved as Vyleesi for HSDD. Activates melanocortin receptors (MC4R/MC3R) centrally in the brain to increase dopamine-mediated desire, unlike PDE-5 inhibitors that act on blood flow alone.

Brain-mediated desire pathway (not blood-flow dependent)

$149.95suggested retail

More peptides coming soon — 120+ in our knowledge base

Ready to offer these protocols to your patients?

Set up your branded storefront in under 5 minutes. Our AI handles patient outreach, protocol matching, renewals, and support.

See it in action